| Particulars | Unit I & II | Unit III | Unit IV | Revat Unit |
|---|---|---|---|---|
| Plant location | Jeedimetla, Telangana | Bhongir, Telangana | Bollaram, Telangana | Ongole, Andhra Pradesh |
| Ownership | Owned | Owned, Acquired in February 2022 | Owned, Acquired in August 2022 | Owned |
| Key approvals | Unit I: GMP Unit II: WHO-GMP |
TGA – Australia, WHO-GMP; PICS | PICS, WHO-GMP | GMP |
| Installed capacity | Dry Powder Injection (Vials) 24 million; Ampoules 18 million; Vials 12 million; PFS 3 million | Tablets 180 million; Liquids 12 million; Ointment 3 million; Capsules 45 million | Tablets 150 million; Capsules 120 million; Dry Powder Injection (Vials) 18 million; Dry Syrups 4.5 million | Tablets 450 million; Capsules 90 million; Syrups 30 million |
| Key dosage forms manufactured | Injections | Tablets, Capsules, liquid orals | Cephalosporin Tablets, Capsules, liquid orals | General Tablets, Capsules, liquid orals |
| Key therapeutic area | Antibiotics | Antipyretic, Antidiabetic, etc | Antibiotic Cephalosporins | Antibiotics, Antihistamine etc |
